IL6 and COVID-19: Peripheral insulin resistance is also induced by the inflammatory response and cytokine storm triggered by COVID-19, characterized by significant increases in the levels of inflammatory markers, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) [141].